Findings from a preclinical study demonstrate that Omomyc—the only direct MYC inhibitor to have successfully completed a phase I clinical trial—causes DNA damage in cancer cells which is synergistically enhanced in combination ...
Dec 2, 2025
0
0
In early adolescence, smartphone ownership is associated with depression, obesity, and insufficient sleep, according to a study published online Dec. 1 in Pediatrics.
Dec 2, 2025
0
2
Predicting who will develop type 1 diabetes is now cheaper and more accessible, thanks to a new tool based on research conducted at the University of Exeter which could one day help determine who to target with recently approved ...
Dec 2, 2025
0
0
As health care costs continue to soar across the U.S., a growing number of states are setting limits on how much hospitals can charge. These policies, known as hospital payment caps, aim to curb spending by tying hospital ...
Dec 2, 2025
0
0
Infectious diseases such as malaria, dengue, and tuberculosis are considered to pose as great a challenge to global health as new or emerging pathogens, according to a major international study led by The Global Health Network ...
Dec 2, 2025
0
0
A new study highlights how important uninterrupted sleep is to recovery after a traumatic brain injury, finding that fragmented sleep in injured mice is linked to a loss of rapid-eye-movement (REM) sleep and increased fatigue.
Dec 2, 2025
0
0
Twenty-two million Americans would no longer be breathing in unhealthy levels of nitrogen dioxide if they switched from gas and propane stoves to electric stoves.
Dec 2, 2025
0
0
A multi-institute team led by St. Jude Children's Research Hospital and UT Southwestern Medical Center investigators established for the first time how certain drugs used to treat epilepsy affect their target.
Dec 2, 2025
0
0
Researchers at The University of Texas MD Anderson Cancer Center have performed a comprehensive evaluation of five artificial intelligence (AI) models trained on genomic sequences, known as DNA foundation language models. ...
Dec 2, 2025
0
0
A cancer-targeting antibody that helps the body's immune cells spot and destroy hard-to-treat tumors such as triple-negative breast cancer has been developed by researchers.
Dec 2, 2025
0
0
